Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HD0G
|
|||
| Drug Name |
SB3
|
|||
| Synonyms |
Antimony cation (3+); Antimony(3+); UNII-069647RPT5; ANTIMONY (III) ION; 069647RPT5; 23713-48-6; antimony(3+) ion; TRIVALENT ANTIMONY; Antimony element; ANTIMONY CATION (3 ); antimony(III) cation; AC1L2XOH; Sb(3+); CHEBI:49867; CTK8D9770; DTXSID10178380; ANTIMONY (III) OXIDE, 99.9%,
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Application submitted | [1] | |
| Company |
Samsung Bioepis Incheon, South Korea
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
Sb+3
|
|||
| Canonical SMILES |
[Sb+3]
|
|||
| InChI |
1S/Sb/q+3
|
|||
| InChIKey |
FAWGZAFXDJGWBB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 23713-48-6
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:49867
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.